A股異動丨新寶股份漲停 7992億養老金已到賬投資
格隆匯10月21日丨新寶股份(002705.SZ)漲停,報14.84元,成交2.2億元,總市值119億元。人社部今日在2019年第三季度新聞發佈會上表示,基金投資運營和監督管理工作穩步推進。截至9月底,已有18個省(區、市)政府與社保基金會簽署基本養老保險基金委託投資合同,合同總金額9660億元,其中7992億元資金已經到賬並開始投資。從最新的前十大流通股股東榜單中,可以看到全國社保四零四組合位列流通股股東榜單第四名,持股數超1401萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.